Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ksenia Keller"'
Autor:
Ksenia Keller, Antje Lebrecht, Heinz Kölbl, Nils Boehm, Dominik Wolters, D Böhm, Marcus Schmidt, W. Siggelkow, Julia Pieter, F. H. Grus, Norbert Pfeiffer
Publikováno v:
Oncology Reports
Noninvasive biomarkers are urgently needed for early detection of breast cancer since the risk of recurrence, morbidity and mortality are closely related to disease stage at the time of primary surgery. In the past decade, many proteomics-based appro
Publikováno v:
Cancer Biology & Therapy. 12:772-779
Noninvasive biomarkers are urgently needed for detecting breast cancer as early as possible since the risk of recurrence, morbidity, and mortality is closely related to disease stage at the time of primary surgery. There are currently no such biomark
Autor:
Marcus Schmidt, Nelli Wehrwein, F. H. Grus, D Böhm, Antje Lebrecht, Heinz Kölbl, Ksenia Keller
Publikováno v:
Oncology reports. 26(5)
Non-invasive biomarkers for early breast cancer detection are urgently needed, as the risk of recurrent morbidity and mortality is closely related to the stage of the disease at the time of primary surgery. Currently, there are no established clinica
Autor:
D. Boehm, Annett Kern, Marcus Schmidt, Christina Cotarelo, Ksenia Keller, Antje Lebrecht, Heinz Koelbl
Publikováno v:
World Journal of Oncology
We describe herein the third case of primary leiomyosarcoma of the breast in a 62-year-old man. Preoperative clinical examination and cytology findings indicated a leiomyosarcoma of the breast. A modified radical mastectomy was performed. Immunohisto
Autor:
Antje Lebrecht, D. Boehm, F. H. Grus, J. Pieter, Ksenia Keller, Heinz Koelbl, Martina Schmidt
Publikováno v:
Journal of Clinical Oncology. 28:e21022-e21022
e21022 Background: Breast cancer is the most common cancer type in women worldwide. Its early detection is a crucial step for the successful treatment. Although many serum biomarkers were described...